# National Bankshares Inc: overview NKSH · Nasdaq · CIK 796534 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/nksh.md) · [Financials](/companies/nksh/financials.md) · [Filings](/companies/nksh/filings.md) · [Insiders](/companies/nksh/insiders.md) Latest reported revenue: [$2.2m](/filings/0001193125-26-346967.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001193125-26-346967). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,875](/filings/0001193125-25-279374.md) | [1,846 d](/filings/0001193125-26-128311.md) | [2,132](/filings/0001193125-26-220869.md) | [1,921](/filings/0001193125-26-346967.md) | [2,078](/filings/0001193125-25-279374.md) | [2,046 d](/filings/0001193125-26-128311.md) | [2,208](/filings/0001193125-26-220869.md) | [2,178](/filings/0001193125-26-346967.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [142.8%](/filings/0001193125-25-279374.md) | [166.8% d](/filings/0001193125-26-128311.md) | [151.8%](/filings/0001193125-26-220869.md) | [119.2%](/filings/0001193125-26-346967.md) | [212.7%](/filings/0001193125-25-279374.md) | [287.4% d](/filings/0001193125-26-128311.md) | [225.6%](/filings/0001193125-26-220869.md) | [230.9%](/filings/0001193125-26-346967.md) | | Diluted EPS | $ per share | [0.42](/filings/0001193125-25-279374.md) | not reported | [0.51](/filings/0001193125-26-220869.md) | [0.36](/filings/0001193125-26-346967.md) | [0.69](/filings/0001193125-25-279374.md) | not reported | [0.78](/filings/0001193125-26-220869.md) | [0.79](/filings/0001193125-26-346967.md) | | Free cash flow | $k | [2,167 d](/filings/0001193125-25-279374.md) | [4,464 d](/filings/0001193125-26-128311.md) | [1,603](/filings/0001193125-26-220869.md) | [1,524 d](/filings/0001193125-26-346967.md) | [5,315 d](/filings/0001193125-25-279374.md) | [6,710 d](/filings/0001193125-26-128311.md) | [3,071](/filings/0001193125-26-220869.md) | [3,322 d](/filings/0001193125-26-346967.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [6.7](/filings/0001437749-23-006097.md) | [7.0](/filings/0001437749-24-008428.md) | [7.1](/filings/0000950170-25-046763.md) | [7.4](/filings/0001193125-26-128311.md) | [8.2](/filings/0001193125-26-128311.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [306.4%](/filings/0001437749-23-006097.md) | [370.8%](/filings/0001437749-24-008428.md) | [221.9%](/filings/0000950170-25-046763.md) | [102.4%](/filings/0001193125-26-128311.md) | [193.6%](/filings/0001193125-26-128311.md) | | Diluted EPS | $ per share | [3.28](/filings/0001437749-22-005975.md) | [4.33](/filings/0001437749-24-008428.md) | [2.66](/filings/0000950170-25-046763.md) | [1.24](/filings/0001193125-26-128311.md) | [2.49](/filings/0001193125-26-128311.md) | | Free cash flow | $m | [22.6](/filings/0001437749-23-006097.md) | [28.2](/filings/0001437749-24-008428.md) | [14.0](/filings/0000950170-25-046763.md) | [6.2](/filings/0001193125-26-128311.md) | [15.2](/filings/0001193125-26-128311.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nksh/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $19.2m | 529,524 | | Added +88,319 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.8m | 268,587 | | Reduced −1,060 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.0m | 164,939 | | Added +14,134 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $5.3m | 147,230 | | Added +12,954 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.3m | 91,917 | | Added +5,842 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $3.2m | 89,238 | | New +89,238 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.3m | 62,670 | | Added +33,690 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $1.9m | 51,847 | | Added +4,204 | | [RBF Capital, LLC](/funds/1134621.md) | 2026-06-30 | $1.8m | 50,000 | | Unchanged | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $1.7m | 45,683 | | Reduced −6,347 | ## Recent filings [All 606 filings](/companies/nksh/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 20:30 ET | [8-K](/filings/0001193125-26-428986.md) | 2.02 Results of operations | 0001193125-26-428986 | | 2026-08-12 | 20:30 ET | [10-Q](/filings/0001193125-26-346967.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346967 | | 2026-07-23 | 20:30 ET | [8-K](/filings/0001193125-26-314195.md) | 2.02 Results of operations | 0001193125-26-314195 | | 2026-07-02 | 20:15 ET | [8-K](/filings/0001193125-26-294550.md) | 8.01 Other events | 0001193125-26-294550 | | 2026-07-01 | 15:40 ET | [8-K](/filings/0001193125-26-291900.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-291900 | | 2026-05-18 | 14:17 ET | [8-K](/filings/0001193125-26-228213.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-228213 | | 2026-05-13 | 20:30 ET | [8-K](/filings/0001193125-26-221751.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-221751 | | 2026-05-13 | 20:30 ET | [8-K](/filings/0001193125-26-221753.md) | 5.07 Shareholder vote results | 0001193125-26-221753 | | 2026-05-13 | 14:45 ET | [10-Q](/filings/0001193125-26-220869.md) | Quarterly report, period 2026-03-31 | 0001193125-26-220869 | | 2026-05-01 | 20:06 ET | [8-K](/filings/0001193125-26-201410.md) | 8.01 Other events | 0001193125-26-201410 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-128311.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 796534 - Tickers: NKSH - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: VA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.